Q1 2017 Earnings Estimate for Mednax, Inc (MD) Issued By Jefferies Group

Mednax, Inc (NYSE:MD) – Stock analysts at Jefferies Group cut their Q1 2017 earnings per share estimates for Mednax in a report released on Tuesday. Jefferies Group analyst B. Tanquilut now forecasts that the brokerage will post earnings of $0.81 per share for the quarter, down from their prior estimate of $0.88. Jefferies Group currently has a “Hold” rating and a $63.00 target price on the stock. Jefferies Group also issued estimates for Mednax’s Q2 2017 earnings at $1.01 EPS, Q3 2017 earnings at $1.08 EPS, Q4 2017 earnings at $1.06 EPS and FY2017 earnings at $3.96 EPS.

Several other research firms also recently commented on MD. Zacks Investment Research downgraded Mednax from a “buy” rating to a “hold” rating in a research note on Tuesday. Goldman Sachs Group, Inc. (The) began coverage on Mednax in a research note on Friday, December 9th. They set a “neutral” rating and a $66.00 price objective for the company. Raymond James Financial, Inc. downgraded Mednax from an “outperform” rating to a “market perform” rating in a research note on Thursday, October 27th. Finally, Mizuho downgraded Mednax from a “buy” rating to a “neutral” rating and cut their target price for the stock from $69.00 to $64.00 in a research note on Wednesday, November 9th. Seven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Mednax currently has a consensus rating of “Hold” and a consensus target price of $71.56.

TRADEMARK VIOLATION NOTICE: “Q1 2017 Earnings Estimate for Mednax, Inc (MD) Issued By Jefferies Group” was reported by sleekmoney and is the sole property of of sleekmoney. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this piece of content can be read at http://sleekmoney.com/q1-2017-earnings-estimate-for-mednax-inc-md-issued-by-jefferies-group/1655442.html.

Shares of Mednax (NYSE:MD) opened at 68.00 on Friday. The stock has a 50 day moving average price of $68.57 and a 200-day moving average price of $66.21. The firm has a market capitalization of $6.35 billion, a price-to-earnings ratio of 19.48 and a beta of 0.67. Mednax has a 52 week low of $59.36 and a 52 week high of $76.96.

Mednax (NYSE:MD) last issued its quarterly earnings results on Tuesday, February 7th. The company reported $1.00 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.06 by $0.06. The firm earned $831 million during the quarter, compared to analyst estimates of $842.15 million. Mednax had a return on equity of 13.59% and a net margin of 10.21%. The business’s revenue was up 12.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.13 earnings per share.

In related news, Director Md Carlo A. Waldemar sold 5,334 shares of the company’s stock in a transaction that occurred on Thursday, February 9th. The stock was sold at an average price of $67.90, for a total value of $362,178.60. Following the sale, the director now owns 16,589 shares in the company, valued at approximately $1,126,393.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Vivian Lopez-Blanco sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 17th. The stock was sold at an average price of $70.95, for a total value of $709,500.00. Following the completion of the sale, the chief financial officer now owns 74,261 shares in the company, valued at approximately $5,268,817.95. The disclosure for this sale can be found here. Corporate insiders own 2.40% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Q1 2017 Earnings Estimate for Mednax, Inc (MD) Issued By Jefferies Group” was reported by sleekmoney and is the sole property of of sleekmoney. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this piece of content can be read at http://sleekmoney.com/q1-2017-earnings-estimate-for-mednax-inc-md-issued-by-jefferies-group/1655442.html.

A number of large investors have recently made changes to their positions in MD. Bremer Trust National Association boosted its stake in shares of Mednax by 0.6% in the third quarter. Bremer Trust National Association now owns 5,025 shares of the company’s stock worth $333,000 after buying an additional 30 shares during the period. Meiji Yasuda Asset Management Co Ltd. boosted its stake in shares of Mednax by 2.2% in the fourth quarter. Meiji Yasuda Asset Management Co Ltd. now owns 4,730 shares of the company’s stock worth $315,000 after buying an additional 100 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Mednax by 0.8% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 13,713 shares of the company’s stock worth $914,000 after buying an additional 103 shares during the period. Advisor Group Inc. boosted its stake in shares of Mednax by 2.6% in the third quarter. Advisor Group Inc. now owns 7,183 shares of the company’s stock worth $442,000 after buying an additional 185 shares during the period. Finally, Capital Fund Management S.A. boosted its stake in shares of Mednax by 6.0% in the third quarter. Capital Fund Management S.A. now owns 3,721 shares of the company’s stock worth $247,000 after buying an additional 210 shares during the period. Hedge funds and other institutional investors own 98.45% of the company’s stock.

Mednax Company Profile

MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.

5 Day Chart for NYSE:MD

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/q1-2017-earnings-estimate-for-mednax-inc-md-issued-by-jefferies-group/1655442.html

Receive News & Ratings for Mednax Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mednax Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *